GlassScriptPhysician profile
Rohit Moudgil
NPI 1952844904
$2,309.57
in general payments reported to CMS, 2019-2025
8 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $203 · 2022: $20.78 · 2023: $137 · 2024: $1,024 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $940 · Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $940.00 |
| Food and Beverage | $582.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $940.00 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $653.85 | 2019-2020 | |
| Pfizer INC. | $157.29 | 2022-2023 | |
| Medtronic, INC. | $156.81 | 2025 | Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $123.69 | 2025 | |
| Medtronic USA, INC. | $112.03 | 2020 | |
| Sumitomo Pharma America, INC. | $83.50 | 2024 | |
| Boston Scientific Corporation | $82.40 | 2025 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Moudgil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.